Duopharma Biotech BhdXKLS:7148 83 Interest Coverage is 7.93 as of Mar. 2026, which is 15% below its 10-year median of 9.35. GuruFocus rates XKLS:7148 with a GF Score™ of 83/100 and a GF Value™ of RM1.52 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 684 Drug Manufacturers companies, Duopharma Biotech Bhd ranks worse than 67.4% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Duopharma Biotech Bhd's
Operating Income
for the
three
months ended in Mar. 2026 was RM44.4 Mil. Duopharma Biotech Bhd's Interest Expense for the
three
months ended in Mar. 2026 was RM-5.6 Mil.
Duopharma Biotech Bhd's interest coverage for the quarter that ended in Mar. 2026 was 7.93.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Duopharma Biotech Bhd's Interest Coverage or its related term are showing as below:
XKLS:7148'
s Interest Coverage Range Over the Past 10 Years
Min: 3.85 Med: 9.35 Max: 13.8
Current: 5.79
XKLS:7148's Interest Coverage is ranked worse than 67.4% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs XKLS:7148: 5.79
Duopharma Biotech Bhd (XKLS:7148) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Duopharma Biotech Bhd Interest Coverage Related Terms
Duopharma Biotech Bhd Interest Coverage Historical Data
* Premium members only.
The historical data trend for Duopharma Biotech Bhd's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
XKLS:7148 vs ZTS, UTHR, VTRS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Duopharma Biotech Bhd Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Duopharma Biotech Bhd's Interest Coverage falls into.
Duopharma Biotech Bhd Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Duopharma Biotech Bhd (XKLS:7148) has a Interest Coverage of 7.93 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Duopharma Biotech Bhd and its competitors. This is 15% below median its historical median of 9.35. Over the past decade, Duopharma Biotech Bhd's Interest Coverage has ranged from 3.85 to 13.80. According to the industry distribution chart, Duopharma Biotech Bhd ranks #461 out of 684 companies in the Drug Manufacturers industry, placing it in the top 67.4%.
Is Duopharma Biotech Bhd's Interest Coverage too high?
Duopharma Biotech Bhd's current Interest Coverage of 7.93 is 15% below median its 10-year median of 9.35. Over the past 10 years, this metric has ranged from a low of 3.85 to a high of 13.80. The Drug Manufacturers industry median Interest Coverage is 12.77. Duopharma Biotech Bhd's value of 7.93 is 37.9% below this industry median. Based on the distribution chart, Duopharma Biotech Bhd ranks #461 out of 684 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Duopharma Biotech Bhd has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Duopharma Biotech Bhd's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Duopharma Biotech Bhd ranks #461 out of 684 companies for Interest Coverage. This places Duopharma Biotech Bhd in the lower half of its industry. The industry median Interest Coverage is 12.77. Duopharma Biotech Bhd's value of 7.93 is 37.9% below this benchmark. Historically, Duopharma Biotech Bhd's own Interest Coverage has ranged from 3.85 to 13.80 over the past decade. While the company's 10-year median is 9.35 vs. the industry median of 12.77, Duopharma Biotech Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Duopharma Biotech Bhd's current Interest Coverage of 7.93 is 37.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Duopharma Biotech Bhd and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Duopharma Biotech Bhd's current Interest Coverage is 7.93, which is 15% below median its own 10-year median of 9.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Duopharma Biotech Bhd stock overvalued right now?
Based on GuruFocus' analysis, Duopharma Biotech Bhd (XKLS:7148) is currently considered Modestly Undervalued. The stock's GF Value™ is RM1.52, compared to a current price of RM1.20 — trading 21.1% below its estimated fair value. The current Interest Coverage is 7.93, which is 15% below median its 10-year median of 9.35 and 37.9% below the Drug Manufacturers industry median of 12.77. Duopharma Biotech Bhd's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Duopharma Biotech Bhd (XKLS:7148), the current Interest Coverage is 7.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Duopharma Biotech Bhd (XKLS:7148) Overvalued in 2026?
Based on GuruFocus' analysis, Duopharma Biotech Bhd stock appears to be undervalued.
The current stock price of RM1.20 is trading 21.1% below its estimated GF Value™ of RM1.52.
GuruFocus considers Duopharma Biotech Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7148:
Interest Coverage: 7.93 (15% below median its 10-year median of 9.35)
GF Value™: RM1.52 vs. price of RM1.20 (21.1% below fair value)
Industry Position: 37.9% below the Drug Manufacturers median (#461 of 684)
No single metric tells the full story. See the XKLS:7148 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. The company develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines. Geographically, the company generates the majority of its revenue from Malaysia.
83GF Score
Get the complete analysis for XKLS:7148
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7148 has been successfully added to your 
